BDO Wealth Advisors’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-50
Closed -$1K 638
2019
Q1
$1K Hold
50
﹤0.01% 584
2018
Q4
$0 Sell
50
-85
-63% -$934 ﹤0.01% 573
2018
Q3
$2K Hold
135
﹤0.01% 556
2018
Q2
$2K Buy
+135
New +$2.04K ﹤0.01% 581

Other funds holding FOLD

BDO Wealth Advisors's FOLD Position: Q2 2019 in Review

BDO Wealth Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2019, closing a stake of 50 shares — an estimated $1K sold.

BDO Wealth Advisors first reported a position in FOLD in Q2 2018 and held it in 4 quarters. The position peaked at $2K in Q3 2018. 206 funds tracked by Wall St. Rank hold FOLD as of Q2 2019.

  • BDO Wealth Advisors reported no remaining Amicus Therapeutics position as of Q2 2019 after selling out during the quarter.
  • BDO Wealth Advisors sold 50 Amicus Therapeutics shares in Q2 2019, an estimated $1K.
  • BDO Wealth Advisors first reported a position in Amicus Therapeutics in Q2 2018 and held it in 4 quarters.
  • BDO Wealth Advisors's Amicus Therapeutics position peaked at $2K in Q3 2018.
  • 206 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2019.

Based on BDO Wealth Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.